(Total Views: 419)
Posted On: 06/30/2020 11:25:46 AM
Post# of 61
$GALT News Article - Galectin Therapeutics Announces Commencement of Patient Enrollment of the Adaptively-Designed Phase 2b/3 Trial of Belapectin in NASH Cirrhosis https://marketwirenews.com/news-releases/gale...33221.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
